Botulinum Toxin Market by Product Type (Toxin Type A and Toxin Type B), by Application (Therapeutic and Aesthetic), by Gender (Male and Female), by Age Group (13–19, 20–29, 30–39, 40–54, and above), by End User (Hospitals, Dermatology Clinics, Spas & Cosm
Description
Botulinum Toxin Market by Product Type (Toxin Type A and Toxin Type B), by Application (Therapeutic and Aesthetic), by Gender (Male and Female), by Age Group (13–19, 20–29, 30–39, 40–54, and above), by End User (Hospitals, Dermatology Clinics, Spas & Cosmetic Centers) – Global Opportunity Analysis and Industry Forecast, 2024–2030
Botulinum Toxin Market
Domain - Materials and Chemicals
Sub Domain - Chemicals
The Botulinum Toxin market size was valued at USD 6.6 billion in 2023, and is predicted to reach USD 11.6 billion by 2030, with a CAGR of 8.51% during the forecast period, 2024–2030.
The rising preference for minimally invasive procedures, such as botulinum toxin injections, further fuels the botulinum toxin market. Patients increasingly opt for treatments that involve lesser risk, shorter recovery times, and fewer complications compared to traditional surgical procedures. According to the latest survey by the International Society of Aesthetic Plastic Surgery (ISAPS), as of 2023, surgical procedures have grown by 16.7%, while non-surgical procedures have increased by 7.2%. Notably, a substantial surge of 57.8% in non-surgical procedures has occurred over the past four years. This trend is driven by a desire for safer and less invasive alternatives to address cosmetic concerns and medical conditions. As a result, the botulinum toxin market is expanding, as it offers patients effective results with minimal disruption to their daily lives and overall well-being. This aligns with the modern preference for convenience and reduced medical intervention.
Moreover, the continuous stream of product approvals from various regulatory bodies drives the botulinum toxin market. These approvals provide a green light for manufacturers to introduce new and improved botulinum toxin-based products to the market. For instance, in August 2023, the U.S. Food and Drug Administration (FDA) approved the first therapeutic indication of Revance's DAXXIFY (DaxibotulinumtoxinA for Injection), specifically for the treatment of cervical dystonia. This approval of DAXXIFY for cervical dystonia marks a significant milestone in expanding its applications beyond the cosmetic use. Thus, such kind of endorsement from regulatory authorities enhances the overall credibility of aesthetic treatments, encouraging widespread adoption and contributing to the market's expansion.
However, adverse effects of botulinum toxin procedures, such as skin reactions, allergies, swallowing difficulties, and neck discomfort, pose limitations that are expected to restrain the growth of the market. On the contrary, the introduction of new botulinum toxins, including DaxibotulinumtoxinA for Injection and Jeuveau, are expected to create ample growth opportunities for the market in the future.
Segment Overview
The global botulinum toxin market is segmented on the basis of product type, application, gender, age group, end user, and region.
By product type, the market is classified into toxin type A and toxin type B.
By application, the market is segmented into therapeutic and aesthetic.
By gender, the market is divided into male and female.
By age group, the market is categorized into 13–19, 20–29, 30–39, 40–54, and above.
By end user, the market is divided into hospitals, dermatology clinics, and spas & cosmetic centers.
Region-wise, the market is segmented into North America, Europe, Asia-Pacific, and the rest of the world (RoW).
The North American market is projected to hold the dominant share by 2030
North America dominates the global botulinum toxin market, and is expected to remain dominant throughout the forecast period. This is attributed to the rising demand for aesthetic plastic surgeries in countries such as the U.S. and Brazil. According to the latest report by the International Society of Aesthetic Plastic Surgery, the U.S. leads globally with over 7.4 million procedures, representing 22% of the total procedures. Brazil follows closely with 8.9%, primarily excelling in surgical procedures. Japan accounts for 7.3%. Regarding the number of plastic surgeons, the U.S. and Brazil are estimated to have the highest numbers, with Asian countries such as Japan, China, and South Korea following closely behind in third, fourth, and fifth place, respectively.
Also, the increased research and development efforts by regional players in North America are fuelling the growth in the botulinum toxin market in the region. For instance, in September 2023, Allergan Aesthetics, a subsidiary of AbbVie, announced positive topline results from a second Phase 3 study for OnabotulinumtoxinA, commonly known as Botox Cosmetic. The study focused on its effectiveness in treating platysma prominence, a condition characterized by visible vertical bands in the neck. This development showcases the ongoing innovations in the botulinum toxin market, highlighting new potential applications for Botox Cosmetic beyond its well-known uses in aesthetics.
Key Market Players
The key players in the botulinum toxin market include:
• Allergan, Inc.
• Merz Pharma GmbH & Co. KGaA
• Ipsen Group
• Revance Therapeutics, Inc.
• Medy-Tox, Inc.
• Hugel, Inc.
• Galderma
• Us Worldmed, Llc
• Evolus, Inc.
• Daewoong Pharmaceutical
Recent Developments
June 2023
Evolus, Inc. launched Nuceiva, a botulinum toxin type A product, in the Italian market. Nuceiva is designed for various aesthetic treatments, and its launch in Italy expands its availability. It offers new options for medical professionals and patients seeking cosmetic enhancements. This expansion signifies Evolus Inc.'s commitment to providing innovative solutions in the field of botulinum toxin products.
May 2023
Daewoong Pharmaceutical, a South Korean pharmaceutical company, invested USD 746 million to expand its production capacity for Botox, a brand of botulinum toxin. This significant investment aims to meet the growing global demand for cosmetic and therapeutic uses of Botox. Daewoong's expansion reflects the rising interest in botulinum toxin products and their applications, indicating a positive trend in the market's growth and development.
June 2022
Galderma announced positive results from two Phase III studies for a novel liquid formulation, indicating a promising advancement in botulinum toxin-based treatments. This innovation showcases Galderma's commitment to enhancing patient experiences and expanding the applications of botulinum toxin-based treatments.
KEY BENEFITS
• The botulinum toxin market report provides a quantitative analysis of the current market and estimations from 2024 to 2030. This analysis assists in identifying the prevailing market opportunities to capitalize on.
• The study comprises a detailed analysis of the botulinum toxin market trends, including the current and future trends to depict prevalent investment pockets in the market.
• The information related to key drivers, restraints, and opportunities and their impact on the botulinum toxin market is provided in the report.
• The competitive analysis of the players along with their market share in the botulinum toxin is provided in the report.
• The SWOT analysis and Porter's Five Forces model are elaborated in the study.
• The value chain analysis in the market study provides a clear picture of the roles of stakeholders.
Table of Contents
428 Pages
- 1. Introduction
- 1.1. Report Description
- 1.2. Who Should Read This Report
- 1.3. Key Market Segments
- 1.4. Research Methodology
- 1.4.1 Secondary Research
- 1.4.2 Data Analysis Framework
- 1.4.3 Market Size Estimation
- 1.4.4 Forecasting
- 1.4.5 Primary Research And Data Validation
- 2. Botulinum Toxin Market – Executive Summary
- 2.1. Market Snapshot, 2022 - 2030, Million Usd
- 3. Market Overview
- 3.1. Market Definition And Scope
- 3.2. Market Dynamics
- 3.2.1 Drivers
- 3.2.1.1 The Surge In Product Development And Approvals
- 3.2.1.2 Upsurge In Demand For Aesthetic Procedures
- 3.2.1.3 Expanding Therapeutic Use Of Botulinum Toxin
- 3.2.2 Restraints
- 3.2.2.1 Short Time Results And Repetitive Nature Of Aesthetic And Therapeutic Procedures
- 3.2.2.2 Adverse Effects Associated With Botulinum Toxin
- 3.2.3 Opportunities
- 3.2.3.1 Large Untapped Population In Emerging Countries
- 4. Covid-19 Analysis
- 4.1. Impact Of Covid-19 On The Market
- 5. Market Share Analysis
- 5.1. Market Share Analysis Of Top Acne Medication Providers, 2020
- 6. Global Botulinum Toxin Market, By Product Type
- 6.1. Overview
- 6.2. Toxin Type A
- 6.2.1 Toxin Type A Market, By Region
- 6.2.1.1 North America Toxin Type A Market, By Country
- 6.2.1.2 Europe Toxin Type A Market, By Country
- 6.2.1.3 Asia-pacific Toxin Type A Market, By Country
- 6.2.1.4 Rest Of World Toxin Type A Market, By Country
- 6.3. Toxin Type B
- 6.3.1 Toxin Type B Market, By Region
- 6.3.1.1 North America Toxin Type B Market, By Country
- 6.3.1.2 Europe Toxin Type B Market, By Country
- 6.3.1.3 Asia-pacific Toxin Type B Market, By Country
- 6.3.1.4 Rest Of World Toxin Type B Market, By Country
- 7. Global Botulinum Toxin Market, By Application
- 7.1. Overview
- 7.2. Therapeutic
- 7.2.1 Global Therapeutic Market, By Application
- 7.2.1.1 Chronic Migraine Market
- 7.2.1.2 Chronic Migraine Market, By Region
- 7.2.1.2.1 North America Chronic Migraine Market, By Country
- 7.2.1.2.2 Europe Chronic Migraine Market, By Country
- 7.2.1.2.3 Asia-pacific Chronic Migraine Market, By Country
- 7.2.1.2.4 Rest Of World Chronic Migraine Market, By Country
- 7.2.1.3 Spasticity Market
- 7.2.1.4 Spasticity Market, By Region
- 7.2.1.4.1 North America Spasticity Market, By Country
- 7.2.1.4.2 Europe Spasticity Market, By Country
- 7.2.1.4.3 Asia-pacific Spasticity Market, By Country
- 7.2.1.4.4 Rest Of World Spasticity Market, By Country
- 7.2.1.5 Overactive Bladder Market
- 7.2.1.6 Overactive Bladder Market, By Region
- 7.2.1.6.1 North America Overactive Bladder Market, By Country
- 7.2.1.6.2 Europe Overactive Bladder Market, By Country
- 7.2.1.6.3 Asia-pacific Overactive Bladder Market, By Country
- 7.2.1.6.4 Rest Of World Overactive Bladder Market, By Country
- 7.2.1.7 Cervical Dystonia Market
- 7.2.1.8 Cervical Dystonia Market, By Region
- 7.2.1.8.1 North America Cervical Dystonia Market, By Country
- 7.2.1.8.2 Europe Cervical Dystonia Market, By Country
- 7.2.1.8.3 Asia-pacific Cervical Dystonia Market, By Country
- 7.2.1.8.4 Rest Of World Cervical Dystonia Market, By Country
- 7.2.1.9 Blepharospasm Market
- 7.2.1.10 Blepharospasm Market, By Region
- 7.2.1.10.1 North America Blepharospasm Market, By Country
- 7.2.1.10.2 Europe Blepharospasm Market, By Country
- 7.2.1.10.3 Asia-pacific Blepharospasm Market, By Country
- 7.2.1.10.4 Rest Of World Blepharospasm Market, By Country
- 7.2.1.11 Axillary Hyperhidrosis Market
- 7.2.1.12 Axillary Hyperhidrosis Market, By Region
- 7.2.1.12.1 North America Axillary Hyperhidrosis Market, By Country
- 7.2.1.12.2 Europe Axillary Hyperhidrosis Market, By Country
- 7.2.1.12.3 Asia-pacific Axillary Hyperhidrosis Market, By Country
- 7.2.1.12.4 Rest Of World Axillary Hyperhidrosis Market, By Country
- 7.2.1.13 Others Market
- 7.2.1.14 Others Market, By Region
- 7.2.1.14.1 North America Others Market, By Country
- 7.2.1.14.2 Europe Others Market, By Country
- 7.2.1.14.3 Asia-pacific Others Market, By Country
- 7.2.1.14.4 Rest Of World Others Market, By Country
- 7.2.2 Therapeutic Market, By Region
- 7.2.2.1 North America Therapeutic Market, By Country
- 7.2.2.2 Europe Therapeutic Market, By Country
- 7.2.2.3 Asia-pacific Therapeutic Market, By Country
- 7.2.2.4 Rest Of World Therapeutic Market, By Country
- 7.3. Aesthetic
- 7.3.1 Aesthetic Market, By Region
- 7.3.1.1 North America Aesthetic Market, By Country
- 7.3.1.2 Europe Aesthetic Market, By Country
- 7.3.1.3 Asia-pacific Aesthetic Market, By Country
- 7.3.1.4 Rest Of World Aesthetic Market, By Country
- 8. Global Botulinum Toxin Market, By Gender
- 8.1. Overview
- 8.2. Male
- 8.2.1 Male Market, By Region
- 8.2.1.1 North America Male Market, By Country
- 8.2.1.2 Europe Male Market, By Country
- 8.2.1.3 Asia-pacific Male Market, By Country
- 8.2.1.4 Rest Of World Male Market, By Country
- 8.3. Female
- 8.3.1 Female Market, By Region
- 8.3.1.1 North America Female Market, By Country
- 8.3.1.2 Europe Female Market, By Country
- 8.3.1.3 Asia-pacific Female Market, By Country
- 8.3.1.4 Rest Of World Female Market, By Country
- 9. Global Botulinum Toxin Market, By Age Group
- 9.1. Overview
- 9.2.-19
- 9.2.1-19 Market, By Region
- 9.2.1.1 North America 13-19 Market, By Country
- 9.2.1.2 Europe 13-19 Market, By Country
- 9.2.1.3 Asia-pacific 13-19 Market, By Country
- 9.2.1.4 Rest Of World 13-19 Market, By Country
- 9.3.-29
- 9.3.1-29 Market, By Region
- 9.3.1.1 North America 20-29 Market, By Country
- 9.3.1.2 Europe 20-29 Market, By Country
- 9.3.1.3 Asia-pacific 20-29 Market, By Country
- 9.3.1.4 Rest Of World 20-29 Market, By Country
- 9.4.-39
- 9.4.1-39 Market, By Region
- 9.4.1.1 North America 30-39 Market, By Country
- 9.4.1.2 Europe 30-39 Market, By Country
- 9.4.1.3 Asia-pacific 30-39 Market, By Country
- 9.4.1.4 Rest Of World 30-39 Market, By Country
- 9.5.-54
- 9.5.1-54 Market, By Region
- 9.5.1.1 North America 40-54 Market, By Country
- 9.5.1.2 Europe 40-54 Market, By Country
- 9.5.1.3 Asia-pacific 40-54 Market, By Country
- 9.5.1.4 Rest Of World 40-54 Market, By Country
- 9.6. And Above
- 9.6.1 And Above Market, By Region
- 9.6.1.1 North America 55 And Above Market, By Country
- 9.6.1.2 Europe 55 And Above Market, By Country
- 9.6.1.3 Asia-pacific 55 And Above Market, By Country
- 9.6.1.4 Rest Of World 55 And Above Market, By Country
- 10. Global Botulinum Toxin Market, By End-user
- 10.1. Overview
- 10.2. Hospitals
- 10.2.1 Hospitals Market, By Region
- 10.2.1.1 North America Hospitals Market, By Country
- 10.2.1.2 Europe Hospitals Market, By Country
- 10.2.1.3 Asia-pacific Hospitals Market, By Country
- 10.2.1.4 Rest Of World Hospitals Market, By Country
- 10.3. Dermatology Clinics
- 10.3.1 Dermatology Clinics Market, By Region
- 10.3.1.1 North America Dermatology Clinics Market, By Country
- 10.3.1.2 Europe Dermatology Clinics Market, By Country
- 10.3.1.3 Asia-pacific Dermatology Clinics Market, By Country
- 10.3.1.4 Rest Of World Dermatology Clinics Market, By Country
- 10.4. Spas & Cosmetic Centers
- 10.4.1 Spas & Cosmetic Centers Market, By Region
- 10.4.1.1 North America Spas & Cosmetic Centers Market, By Country
- 10.4.1.2 Europe Spas & Cosmetic Centers Market, By Country
- 10.4.1.3 Asia-pacific Spas & Cosmetic Centers Market, By Country
- 10.4.1.4 Rest Of World Spas & Cosmetic Centers Market, By Country
- 11. Global Botulinum Toxin Market, By Region
- 11.1. Overview
- 11.2. North America
- 11.2.1 North America Botulinum Toxin Market, By Product Type
- 11.2.2 North America Botulinum Toxin Market, By Application
- 11.2.2.1 North America Therapeutic Market, By Application
- 11.2.3 North America Botulinum Toxin Market, By Gender
- 11.2.4 North America Botulinum Toxin Market, By Age Group
- 11.2.5 North America Botulinum Toxin Market, By End-user
- 11.2.6 North America Botulinum Toxin Market, By Country
- 11.2.6.1 U.S.
- 11.2.6.1.1 U.S. Botulinum Toxin Market, By Product Type
- 11.2.6.1.2 U.S. Botulinum Toxin Market, By Application
- 11.2.6.1.2.1. U.S. Therapeutic Market, By Application
- 11.2.6.1.3 U.S. Botulinum Toxin Market, By Gender
- 11.2.6.1.4 U.S. Botulinum Toxin Market, By Age Group
- 11.2.6.1.5 U.S. Botulinum Toxin Market, By End-user
- 11.2.6.2 Canada
- 11.2.6.2.1 Canada Botulinum Toxin Market, By Product Type
- 11.2.6.2.2 Canada Botulinum Toxin Market, By Application
- 11.2.6.2.2.1. Canada Therapeutic Market, By Application
- 11.2.6.2.3 Canada Botulinum Toxin Market, By Gender
- 11.2.6.2.4 Canada Botulinum Toxin Market, By Age Group
- 11.2.6.2.5 Canada Botulinum Toxin Market, By End-user
- 11.2.6.3 Mexico
- 11.2.6.3.1 Mexico Botulinum Toxin Market, By Product Type
- 11.2.6.3.2 Mexico Botulinum Toxin Market, By Application
- 11.2.6.3.2.1. Mexico Therapeutic Market, By Application
- 11.2.6.3.3 Mexico Botulinum Toxin Market, By Gender
- 11.2.6.3.4 Mexico Botulinum Toxin Market, By Age Group
- 11.2.6.3.5 Mexico Botulinum Toxin Market, By End-user
- 11.3. Europe
- 11.3.1 Europe Botulinum Toxin Market, By Product Type
- 11.3.2 Europe Botulinum Toxin Market, By Application
- 11.3.2.1 Europe Therapeutic Market, By Application
- 11.3.3 Europe Botulinum Toxin Market, By Gender
- 11.3.4 Europe Botulinum Toxin Market, By Age Group
- 11.3.5 Europe Botulinum Toxin Market, By End-user
- 11.3.6 Europe Botulinum Toxin Market, By Country
- 11.3.6.1 Uk
- 11.3.6.1.1 Uk Botulinum Toxin Market, By Product Type
- 11.3.6.1.2 Uk Botulinum Toxin Market, By Application
- 11.3.6.1.2.1. Uk Therapeutic Market, By Application
- 11.3.6.1.3 Uk Botulinum Toxin Market, By Gender
- 11.3.6.1.4 Uk Botulinum Toxin Market, By Age Group
- 11.3.6.1.5 Uk Botulinum Toxin Market, By End-user
- 11.3.6.2 Germany
- 11.3.6.2.1 Germany Botulinum Toxin Market, By Product Type
- 11.3.6.2.2 Germany Botulinum Toxin Market, By Application
- 11.3.6.2.2.1. Germany Therapeutic Market, By Application
- 11.3.6.2.3 Germany Botulinum Toxin Market, By Gender
- 11.3.6.2.4 Germany Botulinum Toxin Market, By Age Group
- 11.3.6.2.5 Germany Botulinum Toxin Market, By End-user
- 11.3.6.3 France
- 11.3.6.3.1 France Botulinum Toxin Market, By Product Type
- 11.3.6.3.2 France Botulinum Toxin Market, By Application
- 11.3.6.3.2.1. France Therapeutic Market, By Application
- 11.3.6.3.3 France Botulinum Toxin Market, By Gender
- 11.3.6.3.4 France Botulinum Toxin Market, By Age Group
- 11.3.6.3.5 France Botulinum Toxin Market, By End-user
- 11.3.6.4 Spain
- 11.3.6.4.1 Spain Botulinum Toxin Market, By Product Type
- 11.3.6.4.2 Spain Botulinum Toxin Market, By Application
- 11.3.6.4.2.1. Spain Therapeutic Market, By Application
- 11.3.6.4.3 Spain Botulinum Toxin Market, By Gender
- 11.3.6.4.4 Spain Botulinum Toxin Market, By Age Group
- 11.3.6.4.5 Spain Botulinum Toxin Market, By End-user
- 11.3.6.5 Italy
- 11.3.6.5.1 Italy Botulinum Toxin Market, By Product Type
- 11.3.6.5.2 Italy Botulinum Toxin Market, By Application
- 11.3.6.5.2.1. Italy Therapeutic Market, By Application
- 11.3.6.5.3 Italy Botulinum Toxin Market, By Gender
- 11.3.6.5.4 Italy Botulinum Toxin Market, By Age Group
- 11.3.6.5.5 Italy Botulinum Toxin Market, By End-user
- 11.3.6.6 Netherlands
- 11.3.6.6.1 Netherlands Botulinum Toxin Market, By Product Type
- 11.3.6.6.2 Netherlands Botulinum Toxin Market, By Application
- 11.3.6.6.2.1. Netherlands Therapeutic Market, By Application
- 11.3.6.6.3 Netherlands Botulinum Toxin Market, By Gender
- 11.3.6.6.4 Netherlands Botulinum Toxin Market, By Age Group
- 11.3.6.6.5 Netherlands Botulinum Toxin Market, By End-user
- 11.3.6.7 Rest Of Europe
- 11.3.6.7.1 Rest Of Europe Botulinum Toxin Market, By Product Type
- 11.3.6.7.2 Rest Of Europe Botulinum Toxin Market, By Application
- 11.3.6.7.2.1. Rest Of Europe Therapeutic Market, By Application
- 11.3.6.7.3 Rest Of Europe Botulinum Toxin Market, By Gender
- 11.3.6.7.4 Rest Of Europe Botulinum Toxin Market, By Age Group
- 11.3.6.7.5 Rest Of Europe Botulinum Toxin Market, By End-user
- 11.4. Asia-pacific
- 11.4.1 Asia-pacific Botulinum Toxin Market, By Product Type
- 11.4.2 Asia-pacific Botulinum Toxin Market, By Application
- 11.4.2.1 Asia-pacific Therapeutic Market, By Application
- 11.4.3 Asia-pacific Botulinum Toxin Market, By Gender
- 11.4.4 Asia-pacific Botulinum Toxin Market, By Age Group
- 11.4.5 Asia-pacific Botulinum Toxin Market, By End-user
- 11.4.6 Asia-pacific Botulinum Toxin Market, By Country
- 11.4.6.1 China
- 11.4.6.1.1 China Botulinum Toxin Market, By Product Type
- 11.4.6.1.2 China Botulinum Toxin Market, By Application
- 11.4.6.1.2.1. China Therapeutic Market, By Application
- 11.4.6.1.3 China Botulinum Toxin Market, By Gender
- 11.4.6.1.4 China Botulinum Toxin Market, By Age Group
- 11.4.6.1.5 China Botulinum Toxin Market, By End-user
- 11.4.6.2 Japan
- 11.4.6.2.1 Japan Botulinum Toxin Market, By Product Type
- 11.4.6.2.2 Japan Botulinum Toxin Market, By Application
- 11.4.6.2.2.1. Japan Therapeutic Market, By Application
- 11.4.6.2.3 Japan Botulinum Toxin Market, By Gender
- 11.4.6.2.4 Japan Botulinum Toxin Market, By Age Group
- 11.4.6.2.5 Japan Botulinum Toxin Market, By End-user
- 11.4.6.3 India
- 11.4.6.3.1 India Botulinum Toxin Market, By Product Type
- 11.4.6.3.2 India Botulinum Toxin Market, By Application
- 11.4.6.3.2.1. India Therapeutic Market, By Application
- 11.4.6.3.3 India Botulinum Toxin Market, By Gender
- 11.4.6.3.4 India Botulinum Toxin Market, By Age Group
- 11.4.6.3.5 India Botulinum Toxin Market, By End-user
- 11.4.6.4 Australia
- 11.4.6.4.1 Australia Botulinum Toxin Market, By Product Type
- 11.4.6.4.2 Australia Botulinum Toxin Market, By Application
- 11.4.6.4.2.1. Australia Therapeutic Market, By Application
- 11.4.6.4.3 Australia Botulinum Toxin Market, By Gender
- 11.4.6.4.4 Australia Botulinum Toxin Market, By Age Group
- 11.4.6.4.5 Australia Botulinum Toxin Market, By End-user
- 11.4.6.5 South Korea
- 11.4.6.5.1 South Korea Botulinum Toxin Market, By Product Type
- 11.4.6.5.2 South Korea Botulinum Toxin Market, By Application
- 11.4.6.5.2.1. South Korea Therapeutic Market, By Application
- 11.4.6.5.3 South Korea Botulinum Toxin Market, By Gender
- 11.4.6.5.4 South Korea Botulinum Toxin Market, By Age Group
- 11.4.6.5.5 South Korea Botulinum Toxin Market, By End-user
- 11.4.6.6 Taiwan
- 11.4.6.6.1 Taiwan Botulinum Toxin Market, By Product Type
- 11.4.6.6.2 Taiwan Botulinum Toxin Market, By Application
- 11.4.6.6.2.1. Taiwan Therapeutic Market, By Application
- 11.4.6.6.3 Taiwan Botulinum Toxin Market, By Gender
- 11.4.6.6.4 Taiwan Botulinum Toxin Market, By Age Group
- 11.4.6.6.5 Taiwan Botulinum Toxin Market, By End-user
- 11.4.6.7 Vietnam
- 11.4.6.7.1 Vietnam Botulinum Toxin Market, By Product Type
- 11.4.6.7.2 Vietnam Botulinum Toxin Market, By Application
- 11.4.6.7.2.1. Vietnam Therapeutic Market, By Application
- 11.4.6.7.3 Vietnam Botulinum Toxin Market, By Gender
- 11.4.6.7.4 Vietnam Botulinum Toxin Market, By Age Group
- 11.4.6.7.5 Vietnam Botulinum Toxin Market, By End-user
- 11.4.6.8 Rest Of Asia-pacific
- 11.4.6.8.1 Rest Of Asia-pacific Botulinum Toxin Market, By Product Type
- 11.4.6.8.2 Rest Of Asia-pacific Botulinum Toxin Market, By Application
- 11.4.6.8.2.1. Rest Of Asia-pacific Therapeutic Market, By Application
- 11.4.6.8.3 Rest Of Asia-pacific Botulinum Toxin Market, By Gender
- 11.4.6.8.4 Rest Of Asia-pacific Botulinum Toxin Market, By Age Group
- 11.4.6.8.5 Rest Of Asia-pacific Botulinum Toxin Market, By End-user
- 11.5. Rest Of World
- 11.5.1 Rest Of World Botulinum Toxin Market, By Product Type
- 11.5.2 Rest Of World Botulinum Toxin Market, By Application
- 11.5.2.1 Rest Of World Therapeutic Market, By Application
- 11.5.3 Rest Of World Botulinum Toxin Market, By Gender
- 11.5.4 Rest Of World Botulinum Toxin Market, By Age Group
- 11.5.5 Rest Of World Botulinum Toxin Market, By End-user
- 11.5.6 Rest Of World Botulinum Toxin Market, By Country
- 11.5.6.1 Latin America
- 11.5.6.1.1 Latin America Botulinum Toxin Market, By Product Type
- 11.5.6.1.2 Latin America Botulinum Toxin Market, By Application
- 11.5.6.1.2.1. Latin America Therapeutic Market, By Application
- 11.5.6.1.3 Latin America Botulinum Toxin Market, By Gender
- 11.5.6.1.4 Latin America Botulinum Toxin Market, By Age Group
- 11.5.6.1.5 Latin America Botulinum Toxin Market, By End-user
- 11.5.6.2 Middle East
- 11.5.6.2.1 Middle East Botulinum Toxin Market, By Product Type
- 11.5.6.2.2 Middle East Botulinum Toxin Market, By Application
- 11.5.6.2.2.1. Middle East Therapeutic Market, By Application
- 11.5.6.2.3 Middle East Botulinum Toxin Market, By Gender
- 11.5.6.2.4 Middle East Botulinum Toxin Market, By Age Group
- 11.5.6.2.5 Middle East Botulinum Toxin Market, By End-user
- 11.5.6.3 Africa
- 11.5.6.3.1 Africa Botulinum Toxin Market, By Product Type
- 11.5.6.3.2 Africa Botulinum Toxin Market, By Application
- 11.5.6.3.2.1. Africa Therapeutic Market, By Application
- 11.5.6.3.3 Africa Botulinum Toxin Market, By Gender
- 11.5.6.3.4 Africa Botulinum Toxin Market, By Age Group
- 11.5.6.3.5 Africa Botulinum Toxin Market, By End-user
- 12. Company Profiles
- 12.1. Abbvie Inc.
- 12.1.1 Company Overview
- 12.1.2 Company Snapshot
- 12.1.3 Product Portfolio
- 12.1.4 Business Performance
- 12.1.5 Sales By Geographic Segment
- 12.1.6 Key Strategic Moves & Developments
- 12.1.7 Primary Market Competitors
- 12.2. Eisai Co., Ltd.
- 12.2.1 Company Overview
- 12.2.2 Company Snapshot
- 12.2.3 Operating Business Segments
- 12.2.4 Product Portfolio
- 12.2.5 Business Performance
- 12.2.6 Sales By Business Segment
- 12.2.7 Sales By Geographic Segment
- 12.2.8 Key Strategic Moves & Developments
- 12.2.9 Primary Market Competitors
- 12.3. Evolus Inc.
- 12.3.1 Company Overview
- 12.3.2 Company Snapshot
- 12.3.3 Product Portfolio
- 12.3.4 Business Performance
- 12.3.5 Key Strategic Moves & Developments
- 12.3.6 Primary Market Competitors
- 12.4. Galderma
- 12.4.1 Company Overview
- 12.4.2 Company Snapshot
- 12.4.3 Product Portfolio
- 12.4.4 Key Strategic Moves & Developments
- 12.4.5 Primary Market Competitors
- 12.5. Hugel, Inc.
- 12.5.1 Company Overview
- 12.5.2 Company Snapshot
- 12.5.3 Product Portfolio
- 12.5.4 Business Performance
- 12.5.5 Key Strategic Moves & Developments
- 12.5.6 Primary Market Competitors
- 12.6. Revance Therapeutics Inc.
- 12.6.1 Company Overview
- 12.6.2 Company Snapshot
- 12.6.3 Operating Business Segments
- 12.6.4 Product Portfolio
- 12.6.5 Business Performance
- 12.6.6 Sales By Business Segment
- 12.6.7 Key Strategic Moves & Developments
- 12.6.8 Primary Market Competitors
- 12.7. Ipsen Pharma
- 12.7.1 Company Overview
- 12.7.2 Company Snapshot
- 12.7.3 Product Portfolio
- 12.7.4 Business Performance
- 12.7.5 Key Strategic Moves & Developments
- 12.7.6 Primary Market Competitors
- 12.8. Merz Pharma Gmbh & Co. Kgaa
- 12.8.1 Company Overview
- 12.8.2 Company Snapshot
- 12.8.3 Product Portfolio
- 12.8.4 Key Strategic Moves & Developments
- 12.8.5 Primary Market Competitors
- 12.9. Us Worldmeds Llc
- 12.9.1 Company Overview
- 12.9.2 Company Snapshot
- 12.9.3 Product Portfolio
- 12.9.4 Key Strategic Moves & Developments
- 12.9.5 Primary Market Competitors
- 12.10. Medytox Inc.
- 12.10.1 Company Overview
- 12.10.2 Company Snapshot
- 12.10.3 Product Portfolio
- 12.10.4 Key Strategic Moves & Developments
- 12.10.5 Primary Market Competitors
- 12.11. Sun Pharmaceutical Industries Limited
- 12.11.1 Company Overview
- 12.11.2 Company Snapshot
- 12.11.3 Product Portfolio
- 12.11.4 Business Performance
- 12.11.5 Sales By Business Segment
- 12.11.6 Sales By Geographic Segment
- 12.11.7 Key Strategic Moves & Developments
- 12.11.8 Primary Market Competitors
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
